Outcomes of Glepaglutide on Intestinal Absorption and Parenteral Support in Patients with Short Bowel Syndrome
{{output}}
Background & aims: Glepaglutide, a long-acting glucagon-like peptide 2 (GLP-2) analog, is under development for the treatment of patients with short bowel syndrome (SBS). GLP-2 enhances intestinal adaptation and absorption. This ... ...
